All lobbying filings

Abbott Laboratories

Abbott Laboratories filed a Q2 report for Abbott Laboratories on July 21, 2025.

Lobbying for Abbott Laboratories

As filed: ABBOTT LABORATORIES for ABBOTT LABORATORIES.

All filings by Abbott Laboratories · Everything Abbott Laboratories has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Expenses

$813,507

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 8

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 6

Health Issues

S. 2477/H.R. 1770 Equitable Community Access to Pharmacist Services Act. Proposals related to medical device cybersecurity. Proposals related to the President's Emergency Plan for AIDS Relief (PEPFAR).

Medicare/Medicaid

Proposals related to Medicare coverage of continuous glucose monitors.

Trade (domestic/foreign)

Proposals related to tariffs on products imported into the United States. Proposals regarding US-China trade negotiations. Proposals related to U.S. global health programs and pandemic preparedness. Proposals to advance global virus surveillance. Proposals related to preserving critical medical supply chains.

Agriculture

H.R. 2300 To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. Proposals related to access to infant formula.

Taxation/Internal Revenue Code

Proposals to reform domestic and international tax structures.

Food Industry (safety, labeling, etc.)

S. 3387 - Ensuring Safe and Toxic-Free Foods Act of 2023. H.R. 9817 Toxic Free Food Act of 2024.

Bills named in this filing 5

S. 2477
Equitable Community Access to Pharmacist Services Act
H.R. 1770
Equitable Community Access to Pharmacist Services Act
H.R. 2300
To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other pu…
S. 3387
Ensuring Safe and Toxic-Free Foods Act of 2023
H.R. 9817
Toxic Free Food Act of 2024

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.